Hot Flasher

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

Hot Flasher is a health podcast hosted by Unknown Host, with 132 episodes on record and a Required Pod Score of 80.

Unknown Host hosts Hot Flasher, a health show with 132 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #137

  Your Eyes, Your Smell, Your Pain — Menopause's Overlooked Side Effects

  Oct 2, 20268 minS1

  JAMA just dedicated a full special issue to menopause and chronic pain — a real signal that the research world is starting to take this seriously. This episode also covers two symptoms that often fly under the radar: dry eyes linked to estrogen decline, and changes in body odor that many women notice but rarely talk about. Key Takeaways: • JAMA's special issue on women's health highlights chronic pain as a major, understudied area of menopause research — validating what many women have reported for years. • Estrogen decline can affect the surface of your eyes, causing dryness, grittiness, or blurred vision; most women don't connect these symptoms to menopause at all. • If your eyes have felt persistently dry or irritated, it's worth mentioning to your doctor and asking whether hormonal changes could be a factor. • Body odor can change during perimenopause and menopause due to shifts in hormone levels, sweat gland activity, and skin pH — not just hot-flash sweating. • The JAMA issue signals a broader shift in how the medical research community is starting to treat menopause: as a serious, multi-system health event rather than a footnote. Sources & References: • JAMA special issue on women's health spotlights menopause and chronic pain (https://www.statnews.com/2026/10/01/womens-health-issues-academic-journal-science-special-edition/) - STAT News • Johnson & Johnson survey finds women not connecting menopause to eye health changes (https://news.google.com/rss/articles/CBMiuAFBVV95cUxQenpHdkNDbUNkWW5CNkFwUm9hWUZBQ1VyNDVvanRkal91d0dwWTZ6SXhIaThyMEp5clVablI4bmtPVGw3YkZkaGRfVnVwVVZaSElLWHlKUFBfdTVqY2dTN3VBcWh5RVZSaWFfTmRacjBXRFdJZ2VFeVB0VzhQN3UyZmdNMFZ6cEx2MzgtZk5RVHlSMTJQVEo5dl9UdlNaX0FWUHJzR3pmN0pfUE0tRXY5WWwtVy1wbnZ4) - Fierce Pharma • Is there really a 'menopause smell'? Expert explains changes in body odour (https://news.google.com/rss/articles/CBMivwFBVV95cUxON1lDRXIxMUNvdTZuQVd5REJRdG9pWjZjM0FhZTkyREVDdkt0NXhuZ3VZbkplSjlweXdUakc4c1lDYjhuOHRyMmpheV9NV1otUHdQSE5LODRwaGtOQ1ZoY05mWHN4WFV4Yk5NZmE4UTV0RDRlVE54ZFY2enFOQ256VzNjMEhkemVPa2xGX05GM05GdUpvOHBpSWx3a09JWElmajdWdnBJU040ZjZrOGJiWHlMS3JqTUxLNk9ZSlMxRQ) - Daily Nation Listen with full show notes: https://hotflasher.com/episodes/2026-10-02-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #136

  Heavy Periods, Iron Levels, and a Cancer Drug's Surprise Role

  Oct 1, 202611 minS1

  This episode covers three research stories: a Chinese retrospective study on endometrial ablation for heavy periods that won't respond to other treatment, new lab research into how the breast cancer drug fulvestrant interacts with estrogen receptors, and a large U.S. dataset connecting iron levels to the pace of biological aging. Key Takeaways: • Endometrial ablation reduced or stopped heavy periods in the majority of patients in this study, but younger age and a larger uterine cavity were associated with higher recurrence rates — worth knowing before deciding. • The fulvestrant study is basic science, not a clinical trial — it maps how the drug interacts with estrogen receptors at the molecular level, which could eventually inform better breast cancer treatments, but it doesn't change anything in clinical practice yet. • The NHANES iron study found that both too little iron and too much iron in the blood were linked to faster biological aging — the relationship is U-shaped, not linear, which makes blanket iron supplementation look questionable. • Biological aging in this study was measured using epigenetic clocks — markers in your DNA that estimate how old your cells are acting, which doesn't always match your actual age. • Iron from food and iron in the bloodstream behaved differently in the data, which is a reason to be cautious about using supplements to chase a number rather than addressing diet first. Sources & References: • Clinical efficacy and predictors of recurrence after hysteroscopic endometrial ablation for abnormal uterine bleeding (https://pubmed.ncbi.nlm.nih.gov/42817781/) - PubMed • ERα proximity labeling study reveals how fulvestrant works at the molecular level (https://pubmed.ncbi.nlm.nih.gov/42816507/) - PubMed • Iron status from diet and blood tests in relation to biological aging acceleration: NHANES cross-sectional study (https://pubmed.ncbi.nlm.nih.gov/42815968/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-10-01-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #135

  Your £400 Supplements Are a Scam (And Other Wednesday Truths)

  Sep 30, 202610 minS1

  Which? analyzed the most popular menopause supplements and found they're nutritionally equivalent to a standard multivitamin that costs twenty times less. This episode also covers an 18-year study connecting the age you reach menopause to long-term brain health, and a new non-invasive test that could spare thousands of women from uncomfortable procedures when they experience post-menopausal bleeding. Key Takeaways: • Popular menopause supplements costing £400+ per year contain the same key nutrients in similar amounts as a £22 standard multivitamin, according to Which? analysis. • An 18-year longitudinal study found that the age at which a woman reaches menopause may be linked to her cognitive health decades later — suggesting menopause timing is about more than fertility. • Earlier menopause (before the average age of around 51) was associated with higher risk of cognitive decline in the study, though the research is observational and cannot prove cause and effect. • UK researchers have developed a test using urine and vaginal fluid samples that could rule out womb cancer in lower-risk women who experience post-menopausal bleeding — potentially replacing invasive hysteroscopies for many. • Post-menopausal bleeding always warrants a conversation with a doctor. It's usually not cancer, but it needs to be checked. Sources & References: • Menopause supplements costing more than £400 a year 'no better than cheap multivitamin' (https://www.theguardian.com/society/2026/sep/30/menopause-supplements-no-better-than-multivitamin-which) - The Guardian • The Age You Reach Menopause May Be Linked to Your Future Brain Health, 18-Year Study Finds (https://news.google.com/rss/articles/CBMiugFBVV95cUxQNjhRX1dpalliakNmeHh4UVFYckJENXNCbE9uTGhITlhfY0xnQUV4OXpfMUlidVBCQmN6UWtWUGEydXFtbVEyN096YlRYTDd1RzZWVDdsNEszdm9BQURpZkFNdzFMenhMc3pJNG93UlR6T2V1a2JUTFFWMWl5X1ozOXJfOTRkMXVRaWNfQS1sc1Qxd3lXcVBMNE9zR3l0QUg4cEZkZnA5SWlwdEoxcjVFcy0taHV1Qmgyb1E) - ScienceAlert • UK doctors develop non-invasive test for womb cancer in women bleeding after menopause (https://www.theguardian.com/society/2026/sep/22/uk-doctors-simple-test-detect-womb-cancer-women-bleeding-menopause) - The Guardian Listen with full show notes: https://hotflasher.com/episodes/2026-09-30-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #134

  When You'll Hit Menopause — And Why It's Not Random

  Sep 29, 202610 minS1

  This episode digs into a new cross-sectional study on what actually predicts the timing of natural menopause — including smoking, breastfeeding history, and BMI — and what those findings mean for understanding your own body. We also cover two studies on cervical health: one tracking ten years of cervical cancer trends in China, and one case report on a focused ultrasound technique being used for early cervical and vaginal cell changes. Key Takeaways: • A cross-sectional study of over 1,000 postmenopausal women in Northwest Iran found that smoking was associated with earlier natural menopause — a finding consistent with research from other populations. • Longer total breastfeeding duration was associated with later menopause in the same study, though the relationship is correlational, not causal. • Higher BMI was associated with later menopause onset, likely because fat tissue produces estrogen, which may delay the transition. • A Chinese study tracking cervical cancer from 2013 to 2022 found shifts in the types of cervical cancer being diagnosed, with HPV vaccination and screening patterns playing a role in the trends. • A case report from 2026 describes sequential use of high-intensity focused ultrasound for low-grade cervical and vaginal cell changes — an early-stage technique, not yet standard care, but worth watching. Sources & References: • Sequential high-intensity focused ultrasound for cervical and vaginal low-grade lesions (https://pubmed.ncbi.nlm.nih.gov/42806959/) - PubMed • Pathological trends in cervical cancer in China, 2013–2022 (https://pubmed.ncbi.nlm.nih.gov/42806628/) - PubMed • Age at natural menopause and associated factors in postmenopausal women in Northwest Iran (https://pubmed.ncbi.nlm.nih.gov/42806577/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-09-29-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes
• 

  Episode #133

  Bone Density, Breast Cancer Surgery, and the Studies Worth Watching

  Sep 28, 202611 minS1

  Today's episode looks at three research papers: a breast cancer surgery trial about whether women with early-stage lobular carcinoma still need lymph node biopsies, a commentary pushing back on a bone-drug study in postmenopausal Chinese women, and a screening tool analysis that quietly raises questions about who gets flagged for osteoporosis — and who doesn't. Key Takeaways: • The SOUND trial showed that many women with early-stage breast cancer can skip sentinel lymph node biopsy, but a new analysis questions whether those findings apply to a specific breast cancer type called invasive lobular carcinoma, which has a higher rate of lymph node involvement than other early-stage cancers. • Eldecalcitol is a vitamin D analog used for postmenopausal osteoporosis in Japan and studied in Chinese women; a new commentary flags methodological concerns in the supporting study, including the lack of a control group and short follow-up — important caveats before anyone treats this as settled evidence. • Osteoporosis screening tools developed and validated in one population often underperform in others; a Japanese men's study is a reminder that fracture risk calculators need to be tested — not assumed — in the groups they're used for. • The gender gap in osteoporosis research runs in both directions: women are underrepresented in cardiovascular trials, but men are often underrepresented in bone health research, which means screening tools calibrated on women may miss at-risk men entirely. • None of these papers are practice-changing on their own, but each one is the kind of evidence your doctor would weigh when making a specific call — the kind of thing worth knowing so you can ask better questions. Sources & References: • Axillary node upstaging in lobular breast cancer — can the SOUND trial results apply? (https://pubmed.ncbi.nlm.nih.gov/42802378/) - PubMed • Commentary on eldecalcitol and calcium supplementation for postmenopausal osteoporosis in Chinese women (https://pubmed.ncbi.nlm.nih.gov/42802291/) - PubMed • How well do osteoporosis screening tools work in elderly Japanese men? (https://pubmed.ncbi.nlm.nih.gov/42802288/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-09-28-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  ListenShow Notes

Recent guests on Hot Flasher. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.